The DOI matches its Crossref record; 203 of the 203 references it cites were found in a registry or an index.
Human dendritic cell subsets: an update
Open accessAbstract
Dendritic cells (DC) are a class of bone-marrow-derived cells arising from lympho-myeloid haematopoiesis that form an essential interface between the innate sensing of pathogens and the activation of adaptive immunity. This task requires a wide range of mechanisms and responses, which are divided between three major DC subsets: plasmacytoid DC (pDC), myeloid/conventional DC1 (cDC1) and myeloid/conventional DC2 (cDC2). Each DC subset develops under the control of a specific repertoire of transcription factors involving differential levels of IRF8 and IRF4 in collaboration with PU.1, ID2, E2-2, ZEB2, KLF4, IKZF1 and BATF3. DC haematopoiesis is conserved between mammalian species and is distinct from monocyte development. Although monocytes can differentiate into DC, especially during inflammation, most quiescent tissues contain significant resident populations of DC lineage cells. An extended range of surface markers facilitates the identification of specific DC subsets although it remains difficult to dissociate cDC2 from monocyte-derived DC in some settings. Recent studies based on an increasing level of resolution of phenotype and gene expression have identified pre-DC in human blood and heterogeneity among cDC2. These advances facilitate the integration of mouse and human immunology, support efforts to unravel human DC function in vivo and continue to present new translational opportunities to medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The three other proteins increased in abundance in TET2-CH were CD1C (a marker of conventional dendritic cells), CLEC4C (a marker of plasmacytoid dendritic cells) and CD86 (a marker of dendritic cells, monocytes and other antigen-presenting cells)51.”
From Rare variant associations with plasma protein levels in the UK Biobank (2023) · cites this paper as [51]
Experimental — accuracy not yet measuredIn the citing paper
“pDCs are instead characterized by a marked impairment of cytokine release in older people (27, 29).”
From Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention (2019) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sallusto, F., & Lanzavecchia, A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.4.1109 · Cited by 5,129
Simultaneous epitope and transcriptome measurement in single cells
Stoeckius, M., Hafemeister, C., Stephenson, W., Houck-Loomis, B., Chattopadhyay, P. K., Swerdlow, H., Satija, R., & Smibert, P. (2017) · Nature Methods · doi:10.1038/nmeth.4380 · Cited by 3,098
Nomenclature of monocytes and dendritic cells in blood
Ziegler‐Heitbrock, L., Ancuța, P., Crowe, S. M., Dalod, M., Grau, V., Hart, D. N. J., Leenen, P. J. M., Liu, Y.-J., MacPherson, G. G., Randolph, G. J., et al. (2010) · Blood · doi:10.1182/blood-2010-02-258558 · Cited by 2,436
Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors
Villani, A.-C., Satija, R., Reynolds, G., Sarkizova, S., Shekhar, K., Fletcher, J., Griesbeck, M., Butler, A., Zheng, S., Lazo, S., et al. (2017) · Science · doi:10.1126/science.aah4573 · Cited by 2,413
The Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood
Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., & Liu, Y.-J. (1999) · Science · doi:10.1126/science.284.5421.1835 · Cited by 2,293
IRF-7 is the master regulator of type-I interferon-dependent immune responses
Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Shimada, N., Ohba, Y., Takaoka, A., Yoshida, N., et al. (2005) · Nature · doi:10.1038/nature03464 · Cited by 2,229
Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation
Liu, S., Cai, X., Wu, J., Cong, Q., Chen, X., Li, T., Du, F., Ren, J., Wu, Y.-T., Grishin, N. V., et al. (2015) · Science · doi:10.1126/science.aaa2630 · Cited by 1,927
Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny
Guilliams, M., Ginhoux, F., Jakubzick, C., Naik, S. H., Onai, N., Schraml, B. U., Segura, É., Tussiwand, R., & Yona, S. (2014) · Nature reviews. Immunology · doi:10.1038/nri3712 · Cited by 1,923
Cella, M., Jarrossay, D., Facchetti, F., Alebardi, O., Nakajima, H., Lanzavecchia, A., & Colonna, M. (1999) · Nature Medicine · doi:10.1038/11360 · Cited by 1,734
Dzionek, A., Fuchs, A., Schmidt, P., Cremer, S., Zysk, M., Miltenyi, S., Buck, D., & Schmitz, J. (2000) · Journal of Immunology · doi:10.4049/jimmunol.165.11.6037 · Cited by 1,433
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 998
Mind the Map: Technology Shapes the Myeloid Cell Space
Günther, P. S., & Schultze, J. L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02287 · Cited by 17
Vázquez‐Madrigal, C., Lopez, S., Grao‐Cruces, E., Millán-Linares, M. C., Rodríguez-Martín, N. M., Martín, M. E., Álba, G., Santa‐María, C., Bermúdez, B., & la Paz, S. M. (2020) · Nutrients · doi:10.3390/nu12103139 · Cited by 18
Immune responses in post kala-azar dermal leishmaniasis
Chatterjee, M., Sengupta, R., Mukhopadhyay, D., Mukherjee, S., Dighal, A., Moulik, S., & Sengupta, S. (2020) · Indian Journal of Dermatology · doi:10.4103/ijd.ijd_258_20 · Cited by 17
“[19] Dermal DCs consist of at least three subpopulations, namely epidermal Langerhans cells (LCs) and two migratory dermal DC (dDCs) subsets, identifiable by CD1a staining [Figure 1a].”
Harvey, A. G., Graves, A. M., Uppalapati, C. K., Matthews, S. M., Rosenberg, S., Parent, E. G., Fagerlie, M. H., Guinan, J., Lopez, B. S., & Kronstad, L. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1006998 · Cited by 17
“Finally, our system investigated only one DC subtype, which fails to recapitulate the diversity of DC subsets found in vivo (87).”
MethodMolecular Markers of Blood Cell Populations Can Help Estimate Aging of the Immune System
Rybtsova, N., Berezina, T. N., & Александрович, Р. С. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065708 · Cited by 18
The role of dendritic cells in radiation-induced immune responses
Kaur, A. P., Alice, A. F., Crittenden, M. R., & Gough, M. J. (2023) · International review of cytology · doi:10.1016/bs.ircmb.2023.02.002 · Cited by 18
Cell-targeted vaccines: implications for adaptive immunity
Ung, T. W.-M., Rutledge, N. S., Weiss, A. M., Esser-Kahn, A. P., & Deak, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1221008 · Cited by 19
Long non-coding RNAs and immune cells: Unveiling the role in viral infections
Zhang, D., Zhang, M., Zhang, L., Wang, W., Hua, S., Zhou, C., & Sun, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115978 · Cited by 17
“LncRNAs have been found to play a crucial role in regulating the differentiation and activation of dendritic cells (DCs) [72].”
BackgroundGuo, J., Muse, E., Christians, A. J., Swanson, S. J., & Dávila, E. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0684 · Cited by 17
“Also, depending upon the cues received byDCs in vivo, they can differentiate into specialized subsets garnering the ability to mediate distinct immune responses (7).”
BackgroundDragomir, M. P., Moisoiu, V., Manaila, R., Pardini, B., Knutsen, E., Anfossi, S., Amit, M., & Călin, G. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113529 · Cited by 17
“DC are broadly classified into classical, plasmacytoid DC, and monocyte-derived inflammatory DC [140].”
BackgroundIgE in the Pathogenesis of SLE: From Pathogenic Role to Therapeutic Target
Lamri, Y., & Charles, N. (2020) · Antibodies · doi:10.3390/antib9040069 · Cited by 17
“The FcεRI is found expressed at lower levels either constitutively or in an inducible way in a trimeric form [αγ2] on the surface of plasmacytoid dendritic cells (pDC), type 2 conventional dendritic cells (cDC2), Langerhans cells, monocytes/macrophages and eosinophils [16,18].”
BackgroundSchmid, H., Ribeiro, E. M., Secker, K.-A., Duerr‐Stoerzer, S., Keppeler, H., Dong, R., Munz, T., Schulze‐Osthoff, K., Hailfinger, S., Schneidawind, C., et al. (2021) · Haematologica · doi:10.3324/haematol.2020.267583 · Cited by 17
“DCs have been categorized in cDCs, pDCs and mo-DCs, considering their lineage and expression of transcription factors such as IFN regulatory factors 8 and 4.(44) In humans, cDCs are potent producers of IL-12 and harbor excellent cross-priming properties.”
Baumgaertner, P., Sankar, M., Herrera, F. G., Benedetti, F., Barras, D., Thierry, A., Laniti, D. D., Kandalaft, L. E., Coukos, G., Xénarios, I., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.633910 · Cited by 17
“In addition, MegaClust detected the expression of CD4 on HLA-DR mDC and pDC demonstrating its capacity to identify rare and infrequently reported populations (24, 32).”
BackgroundVacani-Martins, N., Meuser-Batista, M., dos Santos, C. D. L. P., Hasslocher‐Moreno, A. M., & Henriques‐Pons, A. (2021) · Pathogens · doi:10.3390/pathogens10091074 · Cited by 17
CD303 (BDCA-2) – a potential novel target for therapy in hematologic malignancies
Wilson, N. R., Bover, L. C., Konopleva, M. Y., Han, L., Neelapu, S. S., & Pemmaraju, N. (2021) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2021.1975192 · Cited by 18
Cuypers, F., Schäfer, A., Skorka, S. B., Surabhi, S., Tölken, L. A., Paulikat, A. D., Kohler, T. P., Otto, S. A., Mettenleiter, T. C., Hammerschmidt, S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-00211-y · Cited by 17
Variegated Outcomes of T Cell Activation by Dendritic Cells in the Steady State
Bourque, J., & Hawiger, D. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100932 · Cited by 17
Xu, Z., Qiao, S., Wang, Z., Peng, C., Hou, Y., Liu, B., Cao, G., & Wang, T. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2455508 · Cited by 16
“33,34 Therefore, flow cytometry was used to identify these DC subsets in the LP and MLN in mice with colitis (Figure S4A –”
HIV-1 trans-Infection Mediated by DCs: The Tip of the Iceberg of Cell-to-Cell Viral Transmission
Perez‐Zsolt, D., Regué, D. R., Muñoz‐Basagoiti, J., Aguilar‐Gurrieri, C., Clotet, B., Blanco, J., & Izquierdo‐Useros, N. (2021) · Pathogens · doi:10.3390/pathogens11010039 · Cited by 18
“Viral recognition by DCs triggers the expression of genes involved in the secretion of cytokines and chemokines [49,50], which create a proinflammatory environment to eliminate or limit its replication.”
BackgroundActivation of Cellular Players in Adaptive Immunity via Exogenous Delivery of Tumor Cell Lysates
Seong, J., & Kim, K. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071358 · Cited by 16
“DCs located in the spleen and various lymphoid tissues generally exhibit unique immune functions in activating T cells through antigen presentation [53,54].”
BackgroundActivation, Amplification, and Ablation as Dynamic Mechanisms of Dendritic Cell Maturation
Bourque, J., & Hawiger, D. (2023) · Biology · doi:10.3390/biology12050716 · Cited by 17
“In both mice and humans, DCs comprise two main populations: conventional DCs (cDCs) and plasmacytoid DCs (pDCs) [4–6]. cDCs are additionally divided into the cDC1 and cDC2 subsets as defined by the transcription factors required for their development.”
BackgroundInfluentialDynamic interactome of the MHC I peptide loading complex in human dendritic cells
Barends, M., Koller, N., Schölz, C., Durán, V., Bošnjak, B., Becker, J. S., Döring, M., Blees, H., Förster, R., Kalinke, U., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2219790120 · Cited by 16
Losurdo, A., Muzio, A. D., Cianciotti, B. C., Dipasquale, A., Persico, P., Barigazzi, C., Bono, B., Feno, S., Pessina, F., Santoro, A., et al. (2024) · Cancers · doi:10.3390/cancers16030603 · Cited by 16
“DCs arise from lympho-myeloid hematopoiesis in the bone marrow and may be distinguished into at least two major subsets: conventional/myeloid DCs (cDCs) and plasmocytoid DCs (pDCs) [33].”
BackgroundThe beneficial roles and mechanisms of estrogens in immune health and infection disease
Chen, L., Xu, T., Lou, J., Zhang, T., Wu, S., Xu, J., & Xu, J. (2024) · Steroids · doi:10.1016/j.steroids.2024.109426 · Cited by 17
Qiao, J., Gao, Z., Zhang, C., Hennigs, Wu, B., Jing, L., Gao, R., & Yang, Y. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.132628 · Cited by 16
Flow Cytometry Profiling of Plasmacytoid Dendritic Cell Neoplasms
Hussein, S. E., & Wang, W. (2024) · Cancers · doi:10.3390/cancers16112118 · Cited by 16
“Normal pDC maturation in the bone marrow. pDCs are highlighted in pink. pDCs are highlighted in pink.”
BackgroundCheng, K., Seita, Y., Whelan, E. C., Yokomizo, R., Hwang, Y. S., Rotolo, A., Krantz, I. D., Ginsberg, J. P., Kolon, T. F., Lal, P., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114323 · Cited by 15
Laggner, M., Copic, D., Nemec, L., Vorstandlechner, V., Gugerell, A., Грубер, Ф., Peterbauer, A., Ankersmit, H. J., & Mildner, M. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102774 · Cited by 18
“Dendritic cells (DCs) are professional antigen-presenting cells (APCs) orchestrating adaptive immune responses [1-4].”
BackgroundExamination of Novel Immunomodulatory Effects of L-Sulforaphane
Mazarakis, N., Anderson, J., Toh, Z. Q., Higgins, R. A., Do, L. A. H., Luwor, R. B., Snibson, K. J., Karagiannis, T. C., & Licciardi, P. V. (2021) · Nutrients · doi:10.3390/nu13020602 · Cited by 16
“RANTES is a chemokine that is usually expressed in the late phase immune response following T-cell activation [25] and not activated through the conventional Janus kinase (JAK)/signal transducer and activator of transcription (STAT) (JAK/STAT) pathways involving NFκB [26,27].”
BackgroundMena, J., Alloza, I., Navarro, R. T., Aldekoa, A., Díez‐García, J., Etxebarria, A. V., Lindskog, C., Antigüedad, A. R., Boyero, S., Bilbao, M. D. M. M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.816930 · Cited by 16
Phenotypic and Functional Heterogeneity of Monocyte Subsets in Chronic Heart Failure Patients
Mongirdienė, A., & Liobikas, J. (2022) · Biology · doi:10.3390/biology11020195 · Cited by 15
“Notably, upon entry into tissues, monocytes can develop into two additional types of cells: dendritic cells (Dsc) [68,69] and macrophages [14].”
BackgroundVasudevan, S., Vasquez, J., Chen, W., Aguilar-Rodriguez, B., Niemi, E. C., Zeng, S., Tamaki, W., Nakamura, M. C., & Arjomandi, M. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0085oc · Cited by 15
“By contrast, our subtypes were CD141(1), consistent with observations that with maturation, AXL expression decreases on both cDC-1 and cDC-2 subtypes, whereas CD141 expression decreases along cDC-2 differentiation but remains high on cDC-1 cells (32, 34, 35).”
ResultNano-Carriers of COVID-19 Vaccines: The Main Pillars of Efficacy
Constantin, C., Pisani, A., Bardi, G., & Neagu, M. T. (2021) · Nanomedicine · doi:10.2217/nnm-2021-0250 · Cited by 15
STxB as an Antigen Delivery Tool for Mucosal Vaccination
Tartour, É., & Johannes, L. (2022) · Toxins · doi:10.3390/toxins14030202 · Cited by 15
“For the skin, Langerhans cells and dermal DCs (CD14+) need to be added to this listing [52,53].”
BackgroundJiang, F., Zhang, W., Lu, H., Tan, M., Zeng, Z., Song, Y., Xiao, K., & Lin, F. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.886860 · Cited by 16
“Dendritic cells are most powerful antigen-presenting cells derived from bone marrow and are essential for stimulating adaptive immunity produced by T cells as well as an important bridge between innate and adaptive immunity, and has been found to be associated with cardiac valve tissue inflammation (Skowasch et al., 2…”
BackgroundBoltjes, A., Samat, A. A. K., Plantinga, M., Mokrý, M., Castelijns, B., Swart, J. F., Vastert, S. J., Creyghton, M. P., Nierkens, S., van Loosdregt, J., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1101999 · Cited by 15
Liu, Y., Feng, S., Liu, X., Tang, Y., Li, X., Luo, C., & Tao, J. (2023) · Lara D. Veeken · doi:10.1093/rheumatology/kead117 · Cited by 15
Human dendritic cell subsets in the glioblastoma-associated microenvironment
Hu, X., Jiang, C., Gao, Y., & Xue, X. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578147 · Cited by 15
Lteif, M., Pallardy, M. J., & Turbica, I. (2023) · European Journal of Immunology · doi:10.1002/eji.202250340 · Cited by 16
“…marker expression, and functions into four major subsets: conventional DCs (cDC)s, plasmacytoid DCs (pDC)s, monocyte-derived DCs (moDC)s, and Langerhans cells (LC)s [10]. cDCs comprise two subtypes, cDC1 CD141 + and cDC2 CD11c + , playing a crucial role in Ag uptake and in activating naïve T cells.”
BackgroundMorrison, A. I., Mikula, A. M., Spiekstra, S. W., de Kok, M., Affandi, A. J., Roest, H. P., van der Laan, L. J. W., de Winde, C. M., Koning, J. J., Gibbs, S., et al. (2023) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-023-00609-x · Cited by 16
“DCs exhibit heterogeneous characteristics that divides their status as either plasmacytoid DCs (pDCs) or conventional DCs (cDCs) [10], which can all be found in the LN after their extravasation from blood or lymphatic vessels.”
Immunomodulatory Compounds from the Sea: From the Origins to a Modern Marine Pharmacopoeia
Cutolo, E. A., Campitiello, R., Caferri, R., Pagliuca, V. F., Li, J., Agathos, S. N., & Cutolo, M. (2024) · Marine Drugs · doi:10.3390/md22070304 · Cited by 15
Distinct Immune Homeostasis Remodeling Patterns after HLA‐Matched and Haploidentical Transplantation
Guo, H., Guo, L., Wang, B., Jiang, X., Wu, Z., Mo, X., Sun, Y., Zhang, Y., Wang, Z., Kong, J., et al. (2024) · Advanced Science · doi:10.1002/advs.202400544 · Cited by 14
Dendritic cells in the pathogenesis of ankylosing spondylitis and axial spondyloarthritis
Slobodin, G., Rosner, I., & Kessel, A. (2018) · Clinical Rheumatology · doi:10.1007/s10067-018-4388-4 · Cited by 15
“There are several DC subsets, such as plasmacytoid DCs and two subsets of myeloid DCs with their distinct markers, features, and functions [30].”
BackgroundDendritic cell integrin expression patterns regulate inflammation in the rheumatoid arthritis joint
Schittenhelm, L., Robertson, J., Pratt, A. G., Hilkens, C. M. U., & Morrison, V. L. (2020) · Lara D. Veeken · doi:10.1093/rheumatology/keaa686 · Cited by 15
Vaccination as Immunotherapy in Hematologic Malignancies
Liegel, J. J., Weinstock, M., Rosenblatt, J. M., & Avigan, D. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.01706 · Cited by 15
Vincken, N. L. A., Welsing, P. M. J., Silva‐Cardoso, S. C., Bekker, C. P. J., Lopes, A. P., Nordkamp, M. A. M. O., Leijten, E. F. A., Radstake, T. R. D. J., & Angiolilli, C. (2022) · Experimental Dermatology · doi:10.1111/exd.14566 · Cited by 15
Cuevas, E. S., Roubinet, B., Mouret, S., Thépaut, M., de Fraipont, F., Charles, J., Fieschi, F., Landemarre, L., Chaperot, L., & Aspord, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1120434 · Cited by 15
Intradermal vaccination prevents anti-MOG autoimmune encephalomyelitis in macaques
Fovet, C.-M., Stimmer, L., Contreras, V., Horellou, P., Hubert, A., Seddiki, N., Chapon, C., Tricot, S., Leroy, C., Flament, J., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.052 · Cited by 13
SARS-CoV-2 innate immune recognition and implications for respiratory health
Anang, V., Kumar, P., Pracha, J., Nho, R. S., Mora, A. L., Rojas, M. M., Gowdy, K. M., Yount, J. S., Bednash, J. S., Horowitz, J. C., et al. (2025) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2025.10.008 · Cited by 15
“…viral proteins into antigenic peptides, which are then presented on their surface MHC. MHC class I presentation activates CD8 + cytotoxic T cells, crucial for killing infected cells, while MHC class II presentation activates CD4 + helper T cells that coordinate broader immune responses [158].”
Phosphatase PTPN22 Regulates Dendritic Cell Homeostasis and cDC2 Dependent T Cell Responses
Purvis, H. A., Clarke, F., Montgomery, A. B., Colas, C., Bibby, J. A., Cornish, G. H., Dai, X., Dudziak, D., Rawlings, D. J., Zamoyska, R., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00376 · Cited by 13
Development of Pig Conventional Dendritic Cells From Bone Marrow Hematopoietic Cells in vitro
Li, Y., Puebla-Clark, L., Hernández, J., Díaz, I., & Mateu, E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.553859 · Cited by 14
The Role of Dendritic Cells during Physiological and Pathological Dentinogenesis
Quispe-Salcedo, Á., & Ohshima, H. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10153348 · Cited by 14
“These subsets are generally identified based on the lack of expression for T cells, B cells, natural killer (NK) cells, or other granulocyte-specific markers, high-level expression of major histocompatibility complex (MHC) class II, and lack of monocyte markers [69,74].”
BackgroundNeuronal-Immune Cell Units in Allergic Inflammation in the Nose
Васильевич, K. В., Черевко, Н. А., Klimov, A., & Новиков, П. С. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23136938 · Cited by 14
Dendritic cell transfer for cancer immunotherapy
Zhao, L., Zhang, S., Kepp, O., Kroemer, G., & Liu, P. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.03.003 · Cited by 14
Nagaharu, K., Kojima, Y., Hirose, H., Minoura, K., Hinohara, K., Minami, H., Kageyama, Y., Sugimoto, Y., Masuya, M., Nii, S., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111260 · Cited by 13
Huang, P., Wang, M., Lu, Z., Shi, S., Wei, X., Bi, C., Wang, G., Liu, H., Hu, T., & Wang, B. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109739 · Cited by 14
Reitsema, R. D., Hesselink, B.-C., Abdulahad, W. H., van der Geest, K. S. M., Brouwer, E., Heeringa, P., & van Sleen, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1201575 · Cited by 14
“The function of circulating CD141+ cDC1 is still debated (14, 15), but they are thought to play a role in mediating the efficient recognition of viral and intracellular antigens and subsequently the production of type III interferon.”
BackgroundPan, J., Ye, F., Li, H., Yu, C., Mao, J., Xiao, Y., Chen, H., Wu, J., Li, J., Fei, L., et al. (2023) · Cell Proliferation · doi:10.1111/cpr.13555 · Cited by 13
Alipour, S., Mardi, A., Shajari, N., Kazemi, T., Sadeghi, M. R., Heris, J. A., Masoumi, J., & Baradaran, B. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122686 · Cited by 15
Toghraie, F. S., Bayat, M., Hosseini, M. S., & Ramezani, A. (2025) · Cellular Oncology · doi:10.1007/s13402-025-01051-y · Cited by 18
Role of Dendritic Cells in Exposing Latent HIV-1 for the Kill
Kristoff, J., Rinaldo, C. R., & Mailliard, R. B. (2019) · Viruses · doi:10.3390/v12010037 · Cited by 13
“Identification of cDC1s is also based on shared expression of CD13 and CD33 with cDC2s and low expression of CD11b, CD11c, and CD172 [10]; unique to cDC1s is the receptor that recognizes actin exposed during cell necrosis, CLEC9A [25,26].”
BackgroundInfluentialT Cell Receptor Engineered Lymphocytes for Cancer Therapy
Rollins, M. R., Spartz, E. J., & Stromnes, I. M. (2020) · Current Protocols in Immunology · doi:10.1002/cpim.97 · Cited by 15
“…++++ All cells aMonoclonal antibodies reactive to the indicated antigens are widely available commercially. bProtocols for human DC isolation and maturation have been described (Nair et al., 2012). cFurther characteristics of DCs and their subsets has been reviewed recently (Collin & Bigley, 2018).”
BackgroundAtallah, M. B., Tandon, V., Hiam-Galvez, K. J., Boyce, H., Hori, M., Atallah, W., Spitzer, M. H., Engleman, E. G., & Mallick, P. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-03702-3 · Cited by 14
“Antigen-presenting cells (APCs; here referring to dendritic cells, as described in Note S1) both sense a wide range of inputs and express or secrete numerous immune cell effectors [25].”
BackgroundChamucero-Millares, J. A., Bernal-Estévez, D. A., & Parra-López, C. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104257 · Cited by 14
de Koning, W., Latifi, D., Li, Y.-L., van Eijck, C. V., Stubbs, A., & Mustafa, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.649061 · Cited by 10
Cunningham, S., & Hackstein, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115923 · Cited by 15
Ding, J., Zheng, Y., Wang, G., Zheng, J., & Chai, D. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188763 · Cited by 14
Cutting-Edge Delivery Systems and Adjuvants in Tolerogenic Vaccines: A Review
Puricelli, C., Boggio, E. M., Gigliotti, C. L., Stoppa, I., Sutti, S., Rolla, R., & Dianzani, U. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091782 · Cited by 15
“Four major subtypes of DCs have been described: myeloid-derived type 1 and type 2 conventional DCs (cDC1s and cDC2s) are involved in the cross-presentation of antigens and CD8+ T cells, and the stimulation and polarization of CD4+ Th cells, respectively; lymphoid-derived plasmacytoid DCs (pDCs) quickly secrete type 1…”
BackgroundLi, K., Yang, D., & Liu, D. (2023) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.2c00593 · Cited by 14
Melanoma stem cell vaccine induces effective tumor immunity against melanoma
Yin, Q., Zhao, N., Chang, Y., Dong, M., Xu, M., Xu, W., Jin, H., Liu, W., & Xu, N. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2158670 · Cited by 14
Exploring the relationships between amphibian (Xenopus laevis) myeloid cell subsets
Yaparla, A., Koubourli, D. V., Popović, M., & Grayfer, L. (2020) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2020.103798 · Cited by 14
Recent Advances in Good Manufacturing Practice-Grade Generation of Dendritic Cells
Cunningham, S., & Hackstein, H. (2020) · Transfusion Medicine and Hemotherapy · doi:10.1159/000512451 · Cited by 14
Basit, F., van Oorschot, T. G. M., van Buggenum, J. A. G. L., Derks, R. J. E., Kostidis, S., Giera, M. A., & de Vries, I. J. M. (2021) · Immunology · doi:10.1111/imm.13409 · Cited by 13
Vance, K., Alitinok, A., Winfree, S., Jensen-Smith, H., Swanson, B. J., Grandgenett, P. M., Klute, K. A., Crichton, D. J., & Hollingsworth, M. A. (2022) · Cancer Biomarkers · doi:10.3233/cbm-210308 · Cited by 14
“Though DC10s are known to be tolerogenic and researchers have shown circulating DCs to be correlated to the stage of diagnosis in gastric cancers, similar studies have not been done in the tumor of PDAC patients to determine how they may impact cancer development [35].”
BackgroundInfluentialCell Carriers for Oncolytic Virus Delivery: Prospects for Systemic Administration
Sarkisova, V. A., Dalina, A. A., Neymysheva, D. O., Zenov, M. A., Ilyinskaya, G. V., & Chumakov, P. M. (2025) · Cancers · doi:10.3390/cancers17142296 · Cited by 13
“CCR7 expression was detected on human moDCs studied in vitro [185–187].”
Unraveling function and diversity of bacterial lectins in the human microbiome
Cohen, L. J., Han, S. M., Lau, P., Guisado, D., Liang, Y., Nakashige, T. G., Ali, T. A., Chiang, D., Rahman, A. H., & Brady, S. F. (2022) · Nature Communications · doi:10.1038/s41467-022-29949-3 · Cited by 13
Brückner, M., Fichter, M., Marques, R. D. C., Landfester, K., & Mailänder, V. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081614 · Cited by 14
“In particular, conventional DCs type 1 (cDC1) inherit the potential to efficiently cross-present exogenous antigens enabling them to induce strong cytotoxic T cell responses against tumor cells [22].”
BackgroundMeng, J., Yu, Z., Chen, H., Yu, X., Jiang, M., Zeng, X., & Jian, Y. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154446 · Cited by 13
Catching Our Breath: Updates on the Role of Dendritic Cell Subsets in Asthma
Lajiness, J. D., & Cook‐Mills, J. M. (2023) · Advanced Biology · doi:10.1002/adbi.202200296 · Cited by 13
Das, S., Dash, B. S., Premji, T. P., & Chen, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310546 · Cited by 14
“Human mDCs are further classified into two groups, blood dendritic cells BDCA-1 and BDCA-3, based on the differential surface expression of CDc1 (conventional Dc1) [95].”
BackgroundHeo, Y., Ko, E., Park, S., Park, S.-O., Ahn, B.-C., Yum, J. S., & Chun, E. (2023) · Cancers · doi:10.3390/cancers15153978 · Cited by 13
“DCs are classified as conventional DCs (cDCs) and plasmacytoid DCs (pDCs) based on their phenotype and function [16].”
BackgroundUnlocking Dendritic Cell-Based Vaccine Efficacy through Genetic Modulation—How Soon Is Now?
Elwakeel, A., Bridgewater, H. E., & Bennett, J. (2023) · Genes · doi:10.3390/genes14122118 · Cited by 13
“DC ontogeny and subtype complexity is an ever-evolving field that is not within the scope of this review but has been well characterised elsewhere [5,11,12].”
BackgroundJin, L., Dong, L., Pei, S., Chen, X., Kuang, Y., Chen, W., Zhu, W., & Yin, M. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176382 · Cited by 13
Advances in understanding of dendritic cell in the pathogenesis of acute kidney injury
Lv, D., Jiang, H., Yang, X., Li, Y., Niu, W., & Zhang, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1294807 · Cited by 13
“Human cDC1s are characterized as CD141 + , CD14 - , CLEC9A + , XCR1 + , FLT3 + , and CD103 + (19).”
BackgroundRole of dendritic cells in spinal cord injury
Han, X., Zhang, M., Yan, L., Fu, Y., Kou, H., Shang, C., Wang, J., Liu, H., Jiang, C. Q., Wang, J., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14593 · Cited by 12
“58 They are derived from the precursor cells of the bone marrow's myeloid and lymphoid precursor cells.”
BackgroundDendritic Cells and the Establishment of Fetomaternal Tolerance for Successful Human Pregnancy
Mahajan, D., Kumar, T., Rath, P. K., Sahoo, A. K., Mishra, B. P., Kumar, S., Nayak, N. R., & Jena, M. K. (2024) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.2478/aite-2024-0010 · Cited by 14
Autologous material-inspired drug delivery systems
Feng, H., Cheng, I., Liu, F., Gu, Z., & Li, H. (2024) · Science China Materials · doi:10.1007/s40843-024-2935-y · Cited by 13
“Comprising three major subsets, plasma-cytoid DC, myeloid/conventional DC1, and myeloid/conventional DC2, DCs utilize their antigen-presenting, migratory, and biocompatible attributes to serve as carriers for drug delivery [115].”
Traditional Chinese herbal medicine: harnessing dendritic cells for anti-tumor benefits
Shen, M., Li, Z., Wang, J., Xiang, H., & Xie, Q. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1408474 · Cited by 13
“In fl ammatory situations can give rise to the CC-chemokine receptor 2 (CCR2)-dependent recruitment of monocytes from the blood, which then divide into monocyte-derived DCs (MoDCs) in peripheral tissues (27, 28).”
BackgroundSahni, S., Wang, B., Wu, D., Dhruba, S. R., Nagy, M. R., Patkar, S., Ferreira, I., Day, C., Wang, K., & Ruppin, E. (2024) · Nature Communications · doi:10.1038/s41467-024-52555-4 · Cited by 12
“…in immune response through antigen presentation modulation, we reannotated subsets of macrophages as DCs. Utilizing K-means clustering and PCA analysis on twelve classical DC marker genes 54,55 , this expandedthenumberof celltypesfrom eight toten.”
MethodMimicking Pathogens to Augment the Potency of Liposomal Cancer Vaccines
Twilhaar, M. K. N., Czentner, L., van Nostrum, C. F., Storm, G., & den Haan, J. M. M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13070954 · Cited by 13
Liu, Y., Wang, X., Yang, F., Zheng, Y., Ye, T., & Yang, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.678918 · Cited by 15
Pipperger, L., Riepler, L., Kimpel, J., Siller, A., Stoitzner, P., Bánki, Z., & von Laer, D. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1959140 · Cited by 13
“Among PBMCs three different DC subsets namely pDCs (HLA-DRCD11cCD123), cDC1 (HLA-DRCD11cCD141), and cDC2 (HLA-DR CD11cCD1c) can be found.(42) In Figure 6(a), the gating strategy for the DC subsets based on CD45 single cells is depicted.”
BackgroundYang, C., Wei, Y., Li, W., Wei, J., Chen, G., Xu, M., & Liu, G. (2022) · Journal of Immunology Research · doi:10.1155/2022/6567916 · Cited by 14
“DC cells can be divided into conventional type 1 (cDC1s), conventional type 2 (cDC2s), and plasmacytoid DC (pDCs) [41, 42].”
Baci, D., Cekani, E., Imperatori, A. S., Ribatti, D., & Mortara, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.914890 · Cited by 12
Therapies Targeting Immune Cells in Tumor Microenvironment for Non-Small Cell Lung Cancer
Ye, W., Li, M., & Luo, K.-W. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071788 · Cited by 14
“In the TME, conventional DCs (cDCs), as the typical representatives of mDCs, can be further subdivided into cDC1 and cDC2 spectrums [73]. cDC1 is regulated by transcription factors IRF8, ID2, and BATF3, while cDC2 is regulated by transcription factors IRF4, ID2, ZEB2, and Notch2 [74]. cDC1 is able to cross-present ant…”
BackgroundUnterfrauner, M., Rejeski, H. A., Hartz, A. S., Bohlscheid, S., Baudrexler, T., Feng, X., Rackl, E., Li, L., Rank, A., Velázquez, G. F., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417436 · Cited by 13
Iberg, C. A., & Hawiger, D. (2020) · Antibodies · doi:10.3390/antib9020023 · Cited by 13
“cDCs and pDCs, which develop from bone marrow progenitors, differentiate into various subsets in multiple tissues, and the total cDC population may be further divided into the cDC1 and cDC2 subsets, which are characterized by some degree of specialization [22,29,31,32].”
BackgroundMilenkovic, U., Boeckx, B., Lambrechts, D., Janky, R., Hatzichristodoulou, G., van Renterghem, K., Gevaert, T., Cellek, S., Bivalacqua, T. J., De Ridder, D., et al. (2022) · European Urology Focus · doi:10.1016/j.euf.2021.04.012 · Cited by 14
The Role of Extracellular Vesicles in Allergic Sensitization: A Systematic Review
Tucis, D., Hopkins, G. V., Browne, W. J., James, V. H., Onion, D., & Fairclough, L. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084492 · Cited by 12
“Dendritic cells can be classified into four subsets—human plasmacytoid DC (pDC), conventional DC1 (cDC1), conventional DC2 (cDC2) and monocyte-derived DC (mo-DC) [4].”
BackgroundInamo, J., Fierkens, R., Clay, M. R., Jonsson, A. H., Lin, C., Hayes, K., Rogers, N. D., Leach, H., & Yomogida, K. (2025) · JCI Insight · doi:10.1172/jci.insight.198074 · Cited by 15
“The DC cluster included CLEC9A + X-CR1 + THBD + DC1 and CD1C + CLEC10A + DC2 (24).”
Metadata
- Authors
- Collin, M., & Bigley, V.
- Affiliations
- Newcastle upon Tyne Hospitals NHS Foundation Trust (GB)
- Corresponding author
- Collin, Matthew
- Venue
- Immunology
- Publisher
- Wiley
- Published
- 2018-02-27
- Volume
- 154
- Issue
- 1
- Pages
- 3-20
- ISSN
- 0019-2805 (ISSN-L)
- 1365-2567
- PMC
- PMC5904714
- OpenAlex
- W2781617771
- Cited by
- 1,301
- References
- 203
- Citations by year
- 2026: 69 · 2025: 169 · 2024: 167 · 2023: 191 · 2022: 237 · 2021: 198 · 2020: 155 · 2019: 87 · 2018: 27
- FWCI
- 11.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Immunology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity) (cc-by)
- Funders
- Cancer Research UK (C30484/A21025)
- Wellcome Trust (101155/Z/13/Z)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- dendritic cells, dendritic cell subsets, plasmacytoid dendritic cells, myeloid dendritic cells, DC1, DC2, transcription factors, IRF8, IRF4, PU.1, monocyte-derived dendritic cells, cell surface markers, innate immunity, adaptive immunity
- MeSH terms
- Kruppel-Like Factor 4, Cell Communication, Cell Differentiation, Dendritic Cells, Humans, Immunity, Phenotype, Signal Transduction, Biomarkers, Immunophenotyping
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review